Skip to main content
Top
Published in: Intensive Care Medicine 10/2007

01-10-2007 | Editorial

Invasive aspergillosis in the ICU: an emerging disease

Authors: Wouter Meersseman, Eric Van Wijngaerden

Published in: Intensive Care Medicine | Issue 10/2007

Login to get access

Excerpt

In Intensive Care Medicine Trof and colleagues [1] now present a very useful review of invasive pulmonary aspergillosis (IPA) in the ICU. This is a very timely topic and an increasingly important one given the emerging data in the area. Aspergillus spp. are ubiquitous fungi acquired by inhalation of airborne spores. Humans inhale hundreds of conidia per day without adverse consequences, except for a small minority of persons in whom conidia escape phagocytosis by alveolar macrophages and germinate into hyphae. These hyphael elements can be destroyed by circulating neutrophils. If, however, defense systems fail, a life-threatening angioinvasive form of aspergillosis can develop. The bulk of literature about IPA involves patients with classical risk factors such as prolonged neutropenia and transplant recipients [2, 3]. …
Literature
1.
go back to reference Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes ARJ, Groeneveld ABJ (2007) Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med (DOI 10.1007/s00134-007-0791-z) Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes ARJ, Groeneveld ABJ (2007) Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med (DOI 10.​1007/​s00134-007-0791-z)
2.
go back to reference Segal BH, Walsh TJ (2006) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173:707–717PubMedCrossRef Segal BH, Walsh TJ (2006) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173:707–717PubMedCrossRef
3.
go back to reference Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366:1013–1025PubMedCrossRef Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366:1013–1025PubMedCrossRef
4.
go back to reference Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically III patients without malignancy. Am J Respir Crit Care Med 170:621–625PubMedCrossRef Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically III patients without malignancy. Am J Respir Crit Care Med 170:621–625PubMedCrossRef
5.
go back to reference Vandewoude KH, Blot S, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31PubMedCrossRef Vandewoude KH, Blot S, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31PubMedCrossRef
6.
go back to reference Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena J, Barcenilla F (2005) Isolation of Aspergillus spp from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9:R191–R199PubMedCrossRef Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena J, Barcenilla F (2005) Isolation of Aspergillus spp from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9:R191–R199PubMedCrossRef
7.
go back to reference Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH (2003) Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29:2068–2071PubMedCrossRef Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH (2003) Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29:2068–2071PubMedCrossRef
8.
go back to reference Vandewoude KH, Vogelaers D (2007) Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis 44:380–381PubMedCrossRef Vandewoude KH, Vogelaers D (2007) Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis 44:380–381PubMedCrossRef
9.
go back to reference Perfect JR, Cox GM, Lee JY Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA, Mycoses Study Group (2001) The impact of culture isolation of aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824–1833PubMedCrossRef Perfect JR, Cox GM, Lee JY Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA, Mycoses Study Group (2001) The impact of culture isolation of aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824–1833PubMedCrossRef
10.
go back to reference Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882–885PubMedCrossRef Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882–885PubMedCrossRef
11.
go back to reference Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener M, Singh N (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 42:435–438PubMedCrossRef Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener M, Singh N (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 42:435–438PubMedCrossRef
12.
go back to reference Husain S, Kwak EJ, Obman A, Wagener M, Kusne S, Stout J, McCurry K, Singh N (2004) Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transpl 4:796–802CrossRef Husain S, Kwak EJ, Obman A, Wagener M, Kusne S, Stout J, McCurry K, Singh N (2004) Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transpl 4:796–802CrossRef
13.
go back to reference Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83:1330–1336PubMedCrossRef Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83:1330–1336PubMedCrossRef
14.
go back to reference Sulahian A, Touratier S, Ribaud P (2003) False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349:2366–2377PubMedCrossRef Sulahian A, Touratier S, Ribaud P (2003) False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349:2366–2377PubMedCrossRef
15.
go back to reference Surmont I, Stockman W (2007) Gluconate-containing solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 45:1373PubMedCrossRef Surmont I, Stockman W (2007) Gluconate-containing solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 45:1373PubMedCrossRef
17.
go back to reference Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer, The Global Aspergillus Study Group (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMedCrossRef Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer, The Global Aspergillus Study Group (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMedCrossRef
Metadata
Title
Invasive aspergillosis in the ICU: an emerging disease
Authors
Wouter Meersseman
Eric Van Wijngaerden
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2007
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0792-y

Other articles of this Issue 10/2007

Intensive Care Medicine 10/2007 Go to the issue

END OF LIFE IN ICU: NATIONAL LEGISLATIONS

Care for dying patients – German legislation